Open Morningstar88 opened 1 month ago
Walton Oaks, 11th February 2022 - Pfizer Ltd announced today that Susan Rienow has been appointed UK Managing Director and Country Manager, taking over from Ben Osborn who has been appointed Regional President of Pfizer's Hospital Business Unit for International Developed Markets.
When deciding whether to take legal action against an executive or the company they represent, there are several factors to consider:
Individual Liability: Taking an executive to court directly holds them personally accountable for their actions. If an executive is found liable, their personal assets may be at risk. However, this approach can be more challenging because executives often have legal representation and may argue that their actions were within their professional duties. Company Liability: Suing the company itself focuses on corporate responsibility. If the company is found liable, it may be required to pay damages or change its practices. This approach can be more straightforward, especially if there’s clear evidence of company wrongdoing. Evidence and Documentation: Consider the strength of your evidence. If you have solid proof that an executive’s actions caused harm, pursuing them individually may be worthwhile. If the evidence primarily implicates the company as a whole, suing the company directly might be more effective. Resources and Costs: Legal proceedings can be expensive and time-consuming. Evaluate whether you’re prepared for a potentially lengthy court battle. Suing an executive may involve additional complexities, whereas suing the company may be more streamlined. Public Perception: Consider how your choice will be perceived. Suing an executive can attract media attention and impact their reputation. Suing the company may have broader implications for its brand and public image. Remember that legal advice is essential in making this decision. Consult with an attorney who can assess your specific situation and guide you toward the best course of action. 😊
Once a small claims court orders an executive to pay out, the decision is legally binding. However, if the executive refuses to comply, the claimant can take further steps to enforce the judgment. These steps may include:
Enforcement Proceedings: The claimant can initiate enforcement proceedings to recover the owed amount. This might involve seizing assets, garnishing wages, or placing a charge on property. High Court Enforcement: In England and Wales, you can transfer the judgment to the High Court for enforcement by High Court Enforcement Officers (HCEOs). HCEOs have additional powers compared to county court bailiffs. Charging Order: If the executive owns property, the claimant can apply for a charging order. This places a legal charge on the property, and if it’s sold, the owed amount is paid from the proceeds. Bankruptcy or Insolvency: If the executive is unable to pay, the claimant can explore bankruptcy or insolvency proceedings. However, this is a more complex process. Remember that legal advice is crucial in navigating these options. Consulting with a solicitor or legal professional will help you determine the best course of action based on your specific circumstances. 😊
In the UK, small claims make up approximately 77.8% of the total number of final hearings in the civil courts1. While this statistic provides an overview, the success rate for individual cases can vary based on specific circumstances, evidence, and presentation. Organized paperwork and well-prepared cases are perceived favorably by judges, so ensuring your content stands up in court is crucial2. 😊
Learn more
1
judiciary.uk 2
hcrlaw.com 3
assets.publishing.service.gov.uk 4
gov.uk 5
forums.moneysavingexpert.com +1 more
You've reached the conversation limit for today. Sign in to start a new chat. Chats Copilot GPTs
Copilot Copilot
Designer Designer
Vacation planner Vacation planner
Cooking assistant Cooking assistant
Fitness trainer Fitness trainer
Response stopped
New topic Ask me anything...
Feedback
Pfizer Ltd announced today that Susan Rienow has been appointed UK Managing Director and Country Manager, taking over from Ben Osborn who has been appointed Regional President of Pfizer’s Hospital Business Unit for International Developed Markets.
Susan joined Pfizer over twenty years ago and has been leading the UK Vaccines Business Unit since June 2021, including supporting the UK Vaccines Taskforce and the UK Health Security Agency throughout the 2021-2022 Autumn/Winter booster campaign and launching the paediatric formulation of the Pfizer/BioNTech COVID-19 vaccine. Prior to this, she headed up the UK Hospital Business Unit where she led Pfizer UK’s antimicrobial stewardship efforts in collaboration with UK Government and other UK stakeholders.
Pfizer UK Press Office Tel: 0845 300 8033 Email: pressofficeUK@pfizer.com
My name is Jake Mackenzie, and I swear the following upon my soul, under penalty of perjury.
(1) Pfizer negligently claimed there was a virus in the UK, Europe and the rest of the world.
(2) They claimed that UK citizens, at home and abroad, should get vaccinated.
(3) This caused pressure, arguments and resentment in my family for two years, as I have allergies to many modern vaccine ingredients, and declined to take the vaccine.
(4) Pfizer's negligent, poorly fact checked claim caused loss of earnings in my teaching job, where I lost 80% of my income.
(5) They also agreed with lockdowns, and denial of infrastructure to UK citizens at home and abroad. This was done with the intention of coercing people into taking their lucrative shot.
(6) I also believe they cooperate with Stephen Goedhart, Shepperton Studios, AMC and Heeren Loo to run illegal AR and VR simulations, without the consent of, or payment to, the participants.
Refutation of these self-evident facts must be under Penalty of Perjury. Best Wishes.
starts drivel here:
During the COVID-19 pandemic in the UK, Susan Rienow played a significant role as Pfizer’s UK Managing Director and Country Manager. She led the UK Vaccines Business Unit, supported the UK Vaccines Taskforce, and oversaw the launch of the paediatric formulation of the Pfizer/BioNTech COVID-19 vaccine. Additionally, Ben Osborn, the previous UK Managing Director, contributed to the supply agreement and regulatory authorization for the Pfizer/BioNTech COVID-19 vaccine12. If you have any more questions, feel free to ask!